Simpson Thacher Represents Arrangers in Inaugural $600 Million Senior Secured Revolving Credit Agreement for Sarepta Therapeutics, Inc.



Jessica Tuchinsky Jessica Tuchinsky
Celine (Yang-Lun) Tseng Celine (Yang-Lun) Tseng
Kate M. Burns Kate M. Burns
Jonathan E. Cantor Jonathan E. Cantor
Lori E. Lesser Lori E. Lesser
+5

The Firm represented JPMorgan Chase Bank, N.A. and other financial institutions as Joint Lead Arrangers, Joint Bookrunners, Co-Syndication Agents, and Co-Documentation Agents in connection with Sarepta Therapeutics, Inc.’s (“Sarepta Therapeutics”) $600M revolving credit facility. Borrowings under the facility will be used for general corporate purposes.

Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on helping patients through the discovery and development of unique RNA-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases.

The Simpson Thacher team included Jessica Tuchinsky, Austin Vance, Celine Tseng and Kate Burns (Banking and Credit); Jonathan Cantor (Tax); Lori Lesser, Courtney Welshimer and Matthew Richardson (Intellectual Property); Vanessa Burrows and Jacob Madden (Healthcare/Regulatory); and Pasco Struhs (ECEB).

Team and Contacts